Details
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 20560-20565 |
Seitenumfang | 6 |
Fachzeitschrift | Journal of the American Chemical Society |
Jahrgang | 142 |
Ausgabenummer | 49 |
Frühes Online-Datum | 28 Nov. 2020 |
Publikationsstatus | Veröffentlicht - 9 Dez. 2020 |
Extern publiziert | Ja |
Abstract
Bottromycins are ribosomally synthesized and post-translationally modified peptide natural product antibiotics that are effective against high-priority human pathogens such as methicillin-resistant Staphylococcus aureus. The total synthesis of bottromycins involves at least 17 steps, with a poor overall yield. Here, we report the characterization of the cytochrome P450 enzyme BotCYP from a bottromycin biosynthetic gene cluster. We determined the structure of a close BotCYP homolog and used our data to conduct the first large-scale survey of P450 enzymes associated with RiPP biosynthetic gene clusters. We demonstrate that BotCYP converts a C-terminal thiazoline to a thiazole via an oxidative decarboxylation reaction and provides stereochemical resolution for the pathway. Our data enable the two-pot in vitro production of the bottromycin core scaffold and may allow the rapid generation of bottromycin analogues for compound development.
ASJC Scopus Sachgebiete
- Chemische Verfahrenstechnik (insg.)
- Katalyse
- Chemie (insg.)
- Allgemeine Chemie
- Biochemie, Genetik und Molekularbiologie (insg.)
- Biochemie
- Chemische Verfahrenstechnik (insg.)
- Kolloid- und Oberflächenchemie
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: Journal of the American Chemical Society, Jahrgang 142, Nr. 49, 09.12.2020, S. 20560-20565.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Characterization of the Stereoselective P450 Enzyme BotCYP Enables the in Vitro Biosynthesis of the Bottromycin Core Scaffold
AU - Adam, Sebastian
AU - Franz, Laura
AU - Milhim, Mohammed
AU - Bernhardt, Rita
AU - Kalinina, Olga V.
AU - Koehnke, Jesko
N1 - Funding Information: J.K. thanks the German Research Foundation for an Emmy Noether Fellowship (KO 4116/3-2).
PY - 2020/12/9
Y1 - 2020/12/9
N2 - Bottromycins are ribosomally synthesized and post-translationally modified peptide natural product antibiotics that are effective against high-priority human pathogens such as methicillin-resistant Staphylococcus aureus. The total synthesis of bottromycins involves at least 17 steps, with a poor overall yield. Here, we report the characterization of the cytochrome P450 enzyme BotCYP from a bottromycin biosynthetic gene cluster. We determined the structure of a close BotCYP homolog and used our data to conduct the first large-scale survey of P450 enzymes associated with RiPP biosynthetic gene clusters. We demonstrate that BotCYP converts a C-terminal thiazoline to a thiazole via an oxidative decarboxylation reaction and provides stereochemical resolution for the pathway. Our data enable the two-pot in vitro production of the bottromycin core scaffold and may allow the rapid generation of bottromycin analogues for compound development.
AB - Bottromycins are ribosomally synthesized and post-translationally modified peptide natural product antibiotics that are effective against high-priority human pathogens such as methicillin-resistant Staphylococcus aureus. The total synthesis of bottromycins involves at least 17 steps, with a poor overall yield. Here, we report the characterization of the cytochrome P450 enzyme BotCYP from a bottromycin biosynthetic gene cluster. We determined the structure of a close BotCYP homolog and used our data to conduct the first large-scale survey of P450 enzymes associated with RiPP biosynthetic gene clusters. We demonstrate that BotCYP converts a C-terminal thiazoline to a thiazole via an oxidative decarboxylation reaction and provides stereochemical resolution for the pathway. Our data enable the two-pot in vitro production of the bottromycin core scaffold and may allow the rapid generation of bottromycin analogues for compound development.
UR - http://www.scopus.com/inward/record.url?scp=85097581106&partnerID=8YFLogxK
U2 - 10.1021/jacs.0c10361
DO - 10.1021/jacs.0c10361
M3 - Article
C2 - 33249843
AN - SCOPUS:85097581106
VL - 142
SP - 20560
EP - 20565
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
SN - 0002-7863
IS - 49
ER -